From: An observational study of the discrediting of COX-2 NSAIDs in Australia: Vioxx or class effect?
Characteristicc | Non-Continuous rofecoxib usersa (N = 383) % | Continuous rofecoxib usersb (N = 181) % | Χ2, df, p-value | |
---|---|---|---|---|
Urban Area | 51 | 50 | 0.06, 1, 0.81 | |
Manage on Income | 81 | 75 | 2.96, 1, 0.09 | |
Education (No School) | 73 | 71 | 0.12, 1, 0.73 | |
Marital | Married/De facto | 34 | 35 | Â |
 | Sep/Divorced | 4 | 6 | 1.81, 2, 0.40 |
 | Widowed/Single | 56 | 59 |  |
BMI | Underweight | 2 | 1 | Â |
 | Normal | 47 | 43 | 0.043d |
 | O/weight | 50 | 56 |  |
Smoker | 4 | 6 | 0.89, 1, 0.34 | |
Alcohol | Non-drinker | 69 | 59 | Â |
 | Rarely/Low drinker | 30 | 34 | 0.24d |
 | Risky/High Risk | 1 | 7 |  |
Exc/V. Good/Good General Health | 62 | 59 | 0.29, 1, 0.59 | |
Consulted Family Doctor ≥5 Visits | 73 | 77 | 0.94, 1, 0.33 | |
Hospital Doctor Visit in 12 months | 22 | 24 | 0.35, 1, 0.56 | |
Specialist Doctor Visit in 12 months | 61 | 51 | 4.73, 1, 0.03 | |
Ever Reported Arthritis | 75 | 94 | 31.02, 1, < 0.001 | |
Conditions: | Hypertension | 45 | 38 | 2.62, 1, 0.11 |
 | Depression | 6 | 9 | 1.14, 1, 0.28 |
 | Anxiety/nervous | 7 | 8 | 0.18, 1, 0.68 |
 | Asthma | 8 | 14 | 3.99, 1, 0.05 |
 | Diabetes | 11 | 15 | 1.55, 1, 0.21 |
 | Bronchitis/Emphysema | 6 | 9 | 1.92, 1, 0.17 |
 | Osteoporosis | 29 | 34 | 1.35, 1, 0.25 |
 | Heart Disease | 21 | 30 | 5.23, 1, 0.02 |
 | Cancer | 6 | 4 | 0.96, 1, 0.33 |